Keywords: atrix, miss, targets, higher, costs, nasdaq-listed, laboratories

Atrix to miss targets on higher costs

Article | 29 September 2003

Print This

Nasdaq-listed Atrix Laboratories saw its shares plummet as the company warned that it will struggle to break-even this year following ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in